MediFind
Condition

Hyperlipoproteinemia Type 4

Latest Research

Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Current atherosclerosis reports
  • Treatment Used: Statin Therapy
  • Number of Patients: 0
  • Published —
This article discusses advances in the use of statins for the treatment of familial hypercholesterolemia (FH).
Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Nutrients
  • Treatment Used: Cholesterol-Lowering Diet
  • Number of Patients: 376
  • Published —
This study investigated the impact of cholesterol-lowering diet in patients with familial hypercholesterolemia (high cholesterol).
Latest Advance
Study
  • Condition: Homozygous Familial Hypercholesterolemia
  • Journal: The New England journal of medicine
  • Treatment Used: Evinacumab
  • Number of Patients: 65
  • Published —
This study evaluated the effectiveness of evinacumab for patients with homozygous familial hypercholesterolemia (disease resulting from mutations in both copies of the low-density lipoprotein receptor gene).
Latest Advance
Study
  • Condition: Familial Chylomicronemia Syndrome (FCS) or Hypertriglyceridemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Volanesorsen
  • Number of Patients: 0
  • Published —
This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
Latest Advance
Study
  • Condition: Lipid Treatment During COVID-19
  • Journal: Semergen
  • Treatment Used: Statins and/or Fixed Combination with Ezetimibe and/or iPCSK9
  • Number of Patients: 0
  • Published —
This review of the literature analyzed the safety and effectiveness of lipid lowering therapy in patients with COVID-19.
Latest Advance
Study
  • Condition: Homozygous familial hypercholesterolemia (HoFH)
  • Journal: Current atherosclerosis reports
  • Treatment Used: Lomitapide
  • Number of Patients: 163
  • Published —
The study researched the use of lomitapide for treating homozygous familial hypercholesterolemia (HoFH).
Latest Advance
Study
  • Condition: Children with heterozygous familial hypercholesterolemia
  • Journal: Clinical nutrition ESPEN
  • Treatment Used: Low-fat dietary regimen enriched with soy
  • Number of Patients: 0
  • Published —
The study researched the use of a low-fat dietary regimen enriched with soy for children affected with heterozygous familial hypercholesterolemia.
Latest Advance
Study
  • Condition: Homozygous Familial Hypercholesterolemia
  • Journal: Atherosclerosis
  • Treatment Used: Lipoprotein Apheresis
  • Number of Patients: 50
  • Published —
In this study, researchers evaluated the safety and effectiveness of lipoprotein apheresis for the treatment of children with homozygous familial hypercholesterolemia.
Latest Advance
Study
  • Condition: High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a)
  • Journal: Journal of the American Heart Association
  • Treatment Used: Evolocumab
  • Number of Patients: 7690
  • Published —
This study evaluated the effects of evolocumab on non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B (ApoB).
Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Journal of the American College of Cardiology
  • Treatment Used: Evolocumab
  • Number of Patients: 300
  • Published —
The study researched the effects of Evolocumab for familial hypercholesterolemia.
Latest Advance
Study
  • Condition: Children with Familial Hypercholesterolemia
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Statins
  • Number of Patients: 1177
  • Published —
This study assessed the effectiveness and safety of statins in children with familial hypercholesterolemia
Latest Advance
Study
  • Condition: Homozygous Familial Hypercholesterolemia (HoFH)
  • Journal: The American journal of cardiology
  • Treatment Used: Gemcabene
  • Number of Patients: 8
  • Published —
The present study assessed effectiveness, tolerability, and safety of gemcabene as an additional therapy to current cholesterol-lowering treatment for patients with homozygous familial hypercholesterolemia.